Literature DB >> 19922733

Chronic widespread pain and fibromyalgia: two sides of the same coin?

Roland Staud1.   

Abstract

Chronic widespread pain (CWP) is very prevalent in the general population (5%-10%) and is characterized by pain in all four body quadrants, the neck, and back. CWP differs from localized pain not only in its distribution but also in the way it affects lives. Multiple pain sites are associated with higher pain intensity, longer pain duration, and greater disability. Anxiety and depression are more common in CWP patients than among those with localized pain and pain-free controls. Fibromyalgia (FM) has been classified as CWP of more than a 3-month duration, with mechanical hyperalgesia at > or = 11 tender-point sites. FM has been found in 2% to 4% of community subjects and represents the extreme of CWP. This article compares pain characteristics, quality of life, consequences for daily living, and psychosocial status between FM patients and individuals with CWP. Available evidence shows that FM is associated with more severe symptoms and consequences for daily life and higher pain-severity compared with CWP.

Entities:  

Mesh:

Year:  2009        PMID: 19922733     DOI: 10.1007/s11926-009-0063-8

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


  51 in total

1.  Prevalence of fibromyalgia and chronic widespread pain.

Authors:  L Lindell; S Bergman; I F Petersson; L T Jacobsson; P Herrström
Journal:  Scand J Prim Health Care       Date:  2000-09       Impact factor: 2.581

2.  The course of non-malignant chronic pain: a 12-year follow-up of a cohort from the general population.

Authors:  H Ingemar Andersson
Journal:  Eur J Pain       Date:  2004-02       Impact factor: 3.931

3.  Tender point scores and their relations to signs of mobility, symptoms, and disability in female home care personnel and the prevalence of fibromyalgia syndrome.

Authors:  Gunnar Lundberg; Björn Gerdle
Journal:  J Rheumatol       Date:  2002-03       Impact factor: 4.666

4.  Pain epidemiology and health related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center.

Authors:  Niels Becker; Annemarie Bondegaard Thomsen; Alf Kornelius Olsen; Per Sjøgren; Per Bech; Jørgen Eriksen
Journal:  Pain       Date:  1997-12       Impact factor: 6.961

Review 5.  Mechanisms of disease: pain in fibromyalgia syndrome.

Authors:  Roland Staud; Miguel E Rodriguez
Journal:  Nat Clin Pract Rheumatol       Date:  2006-02

6.  The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses.

Authors:  R Bennett
Journal:  Clin Exp Rheumatol       Date:  2005 Sep-Oct       Impact factor: 4.473

7.  Chronic widespread musculoskeletal pain with or without fibromyalgia: psychological distress in a representative community adult sample.

Authors:  Kevin P White; Warren R Nielson; Manfred Harth; Truls Ostbye; Mark Speechley
Journal:  J Rheumatol       Date:  2002-03       Impact factor: 4.666

8.  Sleep and pain.

Authors:  Harvey Moldofsky
Journal:  Sleep Med Rev       Date:  2001-10       Impact factor: 11.609

9.  Health related quality of life in multiple musculoskeletal diseases: SF-36 and EQ-5D in the DMC3 study.

Authors:  H S J Picavet; N Hoeymans
Journal:  Ann Rheum Dis       Date:  2004-06       Impact factor: 19.103

10.  Population study of tender point counts and pain as evidence of fibromyalgia.

Authors:  P Croft; J Schollum; A Silman
Journal:  BMJ       Date:  1994-09-17
View more
  12 in total

Review 1.  Neurological diseases and pain.

Authors:  David Borsook
Journal:  Brain       Date:  2011-11-08       Impact factor: 13.501

2.  Fibromyalgia Impact and Mindfulness Characteristics in 4986 People with Fibromyalgia.

Authors:  Kim D Jones; Scott D Mist; Marie A Casselberry; Ather Ali; Michael S Christopher
Journal:  Explore (NY)       Date:  2015-04-28       Impact factor: 1.775

3.  Combined musculoskeletal pain in the upper and lower body: associations with occupational mechanical and psychosocial exposures.

Authors:  Tine Gjedde Sommer; Poul Frost; Susanne Wulff Svendsen
Journal:  Int Arch Occup Environ Health       Date:  2015-03-03       Impact factor: 3.015

Review 4.  Juvenile fibromyalgia: current status of research and future developments.

Authors:  Susmita Kashikar-Zuck; Tracy V Ting
Journal:  Nat Rev Rheumatol       Date:  2013-11-26       Impact factor: 20.543

5.  Genome-wide methylation analysis of a large population sample shows neurological pathways involvement in chronic widespread musculoskeletal pain.

Authors:  Gregory Livshits; Ida Malkin; Maxim B Freidin; Yudong Xia; Fei Gao; Jun Wang; Timothy D Spector; Alex MacGregor; Jordana T Bell; Frances M K Williams
Journal:  Pain       Date:  2017-06       Impact factor: 6.961

6.  Risk factors for new onset and persistence of multi-site musculoskeletal pain in a longitudinal study of workers in Crete.

Authors:  Eleni Solidaki; Leda Chatzi; Panos Bitsios; David Coggon; Keith T Palmer; Manolis Kogevinas
Journal:  Occup Environ Med       Date:  2012-08-03       Impact factor: 4.402

7.  The Association between Chronic Widespread Musculoskeletal Pain, Depression and Fatigue Is Genetically Mediated.

Authors:  Andrea Burri; Soshiro Ogata; Gregory Livshits; Frances Williams
Journal:  PLoS One       Date:  2015-11-24       Impact factor: 3.240

8.  The Relationship between Mechanical Hyperalgesia Assessed by Manual Tender Point Examination and Disease Severity in Patients with Chronic Widespread Pain: A Cross-Sectional Study.

Authors:  Kirstine Amris; Eva Ejlersen Wæhrens; Anders Jespersen; Anders Stockmarr; Robert Bennett; Henning Bliddal; Bente Danneskiold-Samsøe
Journal:  Int J Rheumatol       Date:  2014-04-15

9.  Muscle injections with lidocaine improve resting fatigue and pain in patients with chronic fatigue syndrome.

Authors:  Roland Staud; Taylor Kizer; Michael E Robinson
Journal:  J Pain Res       Date:  2017-06-26       Impact factor: 3.133

10.  An omics investigation into chronic widespread musculoskeletal pain reveals epiandrosterone sulfate as a potential biomarker.

Authors:  Gregory Livshits; Alexander J Macgregor; Christian Gieger; Ida Malkin; Alireza Moayyeri; Harald Grallert; Rebecca T Emeny; Tim Spector; Gabi Kastenmüller; Frances M K Williams
Journal:  Pain       Date:  2015-10       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.